Search for: "Celgene Corporation"
Results 1 - 20
of 48
Sort by Relevance
|
Sort by Date
30 Nov 2022, 2:13 pm
Matthew L. [read post]
11 Jan 2022, 6:04 am
Recently, however, Hatch-Waxman plaintiffs in Celgene Corporation v. [read post]
8 Nov 2021, 4:39 am
Celgene Corp. v. [read post]
5 Nov 2021, 8:29 am
Celgene appeals. [read post]
12 Jul 2021, 12:29 am
Celgene International Holdings Corporation The Moscow City Commercial Court fulfilled a claim made by a local generic company Nativa and granted a license to use a patented drug of Celgene International Holdings Corporation in connection to the cancer drug, Lenalidomide-Nativ. [read post]
8 Oct 2020, 9:45 am
Democrats on the House Oversight Committee are pounding Big Pharma executives for price gouging, publishing an 18-month investigation of the soaring costs of select prescription medications and grilling high-paid corporate leaders on whether those meds’ spiking prices were all too prevalent in the profit-ravenous drug industry. [read post]
4 Jun 2020, 2:58 am
Sony Corporation, No. 19-601; Celgene Corporation v. [read post]
11 Nov 2019, 9:55 am
[Celgene Petition Rehearing]. [read post]
15 Aug 2019, 10:00 am
In CELGENE CORPORATION v. [read post]
1 Aug 2019, 8:34 pm
” In Celgene Corporation v. [read post]
24 Apr 2019, 3:00 am
Celgene shares fell 8% in a matter of hours. [read post]
2 Apr 2019, 6:50 am
Cyberspace is not a “No Law Land”. [read post]
30 Jan 2019, 5:44 am
M&A being lumpy and unpredictable as ever, 2019 has opened with a number of notable deals, not least the sale of Celgene to Bristol-Myers Squibb for $95 billion, somewhat defying gloomy predictions for the year. [read post]
25 Jun 2018, 3:49 am
In doing so, the courts used to rely on Bolar Principle interpreting such clearly profit-driven actions as registration of price to be preparatory actions that cannot bear threat of infringement (Celgene Corporation vs. [read post]
16 Nov 2017, 6:17 am
Company Name Annual Director Retainer Regeneron Pharmaceuticals $2,074,085 Tesla $1,664,928 The Goldman Sachs Group $575,000 Salesforce.com $550,000 Celgene Corporation $524,871 Reynolds American $496,480 Valeant Pharmaceuticals International $475,000 Allergan PLC $450,000 Everest Re Group, Ltd. $447,030 Oracle $429,172 (more…) [read post]
27 Jul 2017, 5:28 am
Celgene Corporation, a pharmaceuticals manufacturer headquartered in Summit, New Jersey will pay $280 million to settle fraud allegations related to the “off-label” promotion of two cancer treatment drugs for uses not approved by the Food and Drug Administration (“FDA”). [read post]
27 Jul 2017, 5:28 am
Celgene Corporation, a pharmaceuticals manufacturer headquartered in Summit, New Jersey will pay $280 million to settle fraud allegations related to the “off-label” promotion of two cancer treatment drugs for uses not approved by the Food and Drug Administration (“FDA”). [read post]
10 Apr 2017, 5:00 am
By Jacquelyn LumbThe Division of Corporation Finance advised Celgene Corporation that it was unable to concur with the company’s view that it could omit a shareholder proposal seeking a bylaw to prevent the board from seeing a tally of votes cast on certain executive pay matters. [read post]
10 Feb 2017, 9:46 pm
The Supreme Court decision was almost immediately cited by an Australian Patent Hearing Officer, who found that a claimed method for commercialising inventions does not constitute patentable subject matter under the Australian ‘manner of manufacture’ test: Invention Pathways Pty Ltd [2010] APO 10.The Invention Pathways decision resulted in an official change to Australian Patent Office practice whereby a claimed invention, to be patent-eligible, would not only need to involve a… [read post]
12 Oct 2015, 12:46 pm
The first bit of good news for Bass came with respect to his IPR petition against Celgene Corporation. [read post]
